Paul E Verweij Selected Research

posaconazole

7/2022	Posaconazole bioavailability of the solid oral tablet is reduced during severe intestinal mucositis.
6/2022	Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU study.
1/2021	Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.
5/2020	Pharmacokinetics and Pharmacodynamics of Posaconazole.
2/2020	High-dose posaconazole for azole-resistant aspergillosis and other difficult-to-treat mould infections.
1/2020	Implications for IV posaconazole dosing in the era of obesity.
3/2018	Current antifungal treatment of fusariosis.
7/2017	Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
6/2017	Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole.
3/2015	Posaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul E Verweij Research Topics

Disease

78	Aspergillosis 12/2021 - 01/2003
40	Infections 12/2021 - 10/2002
15	Mycoses (Diseases, Fungus) 01/2022 - 09/2006
12	Pulmonary Aspergillosis 06/2022 - 08/2006
10	Invasive Pulmonary Aspergillosis 12/2022 - 05/2014
10	Invasive Fungal Infections 01/2022 - 05/2009
9	Human Influenza (Influenza) 06/2022 - 01/2017
9	Keratitis 09/2021 - 01/2003
9	Candidiasis (Moniliasis) 01/2020 - 09/2005
8	Body Weight (Weight, Body) 01/2017 - 06/2002
7	Critical Illness (Critically Ill) 06/2022 - 09/2008
7	COVID-19 05/2022 - 09/2020
7	Neoplasms (Cancer) 01/2022 - 01/2015
7	Chronic Granulomatous Disease 01/2017 - 01/2003
5	Neutropenia 03/2018 - 08/2009
5	Abscess 12/2009 - 12/2003
4	Disease Progression 01/2022 - 11/2004
4	Mucormycosis 06/2020 - 11/2016
3	Coinfection 02/2022 - 11/2008
3	Inflammation (Inflammations) 01/2021 - 01/2015
3	Invasive Candidiasis 01/2016 - 08/2009
3	HIV Infections (HIV Infection) 01/2015 - 08/2006
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2012 - 09/2008
3	Peritonitis 12/2009 - 07/2007
2	Communicable Diseases (Infectious Diseases) 02/2022 - 11/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2015
2	Fever (Fevers) 01/2022 - 04/2012
2	Obesity 01/2022 - 01/2020
2	Onychomycosis (Tinea Unguium) 01/2022 - 03/2018
2	Tinea (Ringworm) 11/2021 - 01/2021
2	Pneumonia (Pneumonitis) 03/2021 - 10/2018
2	Lung Diseases (Lung Disease) 01/2021 - 07/2015
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 07/2017
2	Wounds and Injuries (Trauma) 01/2019 - 11/2009
2	Cryptococcal Meningitis 01/2018 - 11/2004
2	Meningitis 05/2013 - 02/2004
2	Abdominal Abscess 07/2007 - 12/2003
2	Necrosis 11/2005 - 01/2003
2	Zygomycosis (Phycomycosis) 11/2003 - 06/2002
1	Mucositis 07/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Atrial Fibrillation 01/2022

Drug/Important Bio-Agent (IBA)

47	AzolesIBA 01/2021 - 06/2002
31	Voriconazole (Vfend)FDA LinkGeneric 12/2022 - 05/2003
19	TriazolesIBA 12/2022 - 04/2007
18	posaconazole FDA Link 07/2022 - 11/2003
11	galactomannanIBA 12/2021 - 01/2004
10	Amphotericin B (Amphotericin)FDA LinkGeneric 05/2022 - 06/2002
10	AntigensIBA 12/2021 - 02/2004
9	Pharmaceutical PreparationsIBA 02/2022 - 06/2002
9	Antifungal AgentsIBA 01/2022 - 12/2003
9	Itraconazole (Sporanox)FDA LinkGeneric 03/2018 - 06/2002
7	liposomal amphotericin B FDA Link 02/2020 - 03/2008
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2004
5	Fluconazole (Zonal)FDA LinkGeneric 01/2022 - 12/2003
5	Terbinafine (Lamisil)FDA LinkGeneric 11/2021 - 06/2002
5	Caspofungin (Cancidas)FDA Link 01/2016 - 08/2006
5	Interleukin-10 (Interleukin 10)IBA 07/2014 - 01/2003
4	Micafungin (FK463)FDA Link 01/2018 - 07/2015
4	EchinocandinsIBA 12/2016 - 04/2010
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007 - 01/2003
4	CytokinesIBA 11/2005 - 01/2003
3	isavuconazoleIBA 01/2018 - 01/2015
3	Formaldehyde (Formol)FDA Link 01/2018 - 04/2010
3	ParaffinIBA 01/2018 - 04/2010
3	Interferon-gamma (Interferon, gamma)IBA 07/2014 - 11/2004
3	Anidulafungin FDA Link 02/2013 - 01/2013
3	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2009 - 07/2007
2	TabletsIBA 07/2022 - 05/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 04/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 10/2018
2	Monoclonal AntibodiesIBA 02/2022 - 06/2004
2	SteroidsIBA 01/2022 - 01/2017
2	Natamycin (Pimaricin)FDA Link 03/2021 - 03/2018
2	ChlorhexidineIBA 03/2021 - 01/2019
2	luliconazoleIBA 11/2019 - 02/2019
2	Sodium Glutamate (Accent)IBA 01/2019 - 10/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 05/2006
2	Flucytosine (Ancobon)FDA Link 07/2015 - 12/2008
2	ProdrugsIBA 05/2015 - 01/2015
2	deoxycholate drug combination amphotericin BIBA 10/2013 - 03/2008
2	Codon (Codons)IBA 04/2013 - 04/2009
2	MannansIBA 11/2011 - 02/2004
2	EnzymesIBA 04/2008 - 05/2007
2	Interleukin-6 (Interleukin 6)IBA 07/2007 - 01/2003
1	CitrullineIBA 07/2022
1	remdesivirIBA 02/2022
1	favipiravirIBA 02/2022
1	tocilizumab (atlizumab)FDA Link 02/2022
1	Oxygen (Dioxygen)IBA 02/2022

Therapy/Procedure

44	Therapeutics 12/2022 - 06/2002
7	Drug Therapy (Chemotherapy) 01/2022 - 08/2009
4	Critical Care (Surgical Intensive Care) 02/2022 - 09/2020
4	Hematopoietic Stem Cell Transplantation 06/2020 - 03/2011
3	Salvage Therapy 02/2020 - 10/2013
2	Artificial Respiration (Mechanical Ventilation) 05/2022 - 01/2022
2	Debridement 06/2020 - 12/2009
2	Contact Lenses 01/2020 - 01/2019
2	Corneal Transplantation (Keratoplasty) 01/2020 - 06/2005
2	Stem Cell Transplantation 01/2019 - 01/2015